Europska Unija - hrvatski - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - karcinom, squamous cell - antineoplastična sredstva - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medik zagreb d.o.o., zagreb - uređaj za ultrazvučnu dijagnostiku

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medik zagreb d.o.o., zagreb - uređaj za ultrazvučnu dijagnostiku

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medik zagreb d.o.o., zagreb - dijagnostika ultrazvučnim valovima

Europska Unija - hrvatski - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastična sredstva - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Europska Unija - hrvatski - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - imunosupresivi - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

industrial veterinaria, s.a., esmeralda 19, e-08950 esplugues de llobregat (barcelona), Španjolska - medetomidin hidroklorid - otopina za injekciju - hhipnotici i sedativi - pasa, mačaka

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

industrial veterinaria, s.a., esmeralda 19, e-08950 esplugues de llobregat (barcelona), Španjolska - medetomidin hidroklorid - otopina za injekciju za pse i mačke - pasa, mačaka

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medimon d.o.o., split - setovi koji povezuju transfuziju s pacijentom

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medimon d.o.o., split - set za infuziju